EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 7

White mulberry leaf Morus alba L.

Also called: mulberry leaf, white mulberry

White mulberry (Morus alba) is a tree native to central China. Supplements and most human trials use its leaf, as powder or extract; some products and trials are dosed by their content of 1-deoxynojirimycin (DNJ), an alpha-glucosidase inhibitor.

Category
Botanical
Part used
Leaf (powder or extract)
Strongest evidence
B Some positive trials
Native range
Native to central China (POWO: "C. China")
Reviewed
2026-10-30

Class 1 Well studied in people. A 2022 systematic review and meta-analysis included 13 RCTs (in 10 articles; 10 to 85 participants each) of Morus alba alone; it notes that an earlier meta-analysis also included combination products. [3]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what White mulberry leaf does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for White mulberry leaf, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Fasting glucose, HbA1c and insulin in adultsBA 2023 meta-analysis of 12 trials (615 participants) found mulberry leaf or leaf extract lowered fasting glucose by 0.47 mmol/L, HbA1c by 2.92 mmol/mol and fasting insulin by 0.58 μIU/mL. [1]
Blood glucose after mealsBA 2017 meta-analysis of 13 RCTs of Morus alba products found lower post-meal glucose at 30, 60 and 90 minutes, but no difference in fasting glucose, HbA1c or HOMA-IR. [2]
Overall blood sugar management (2022 review)CA 2022 systematic review of RCTs found Morus alba can reduce post-meal glucose and insulin but judged the evidence insufficient to conclude it is effective for lowering blood glucose. [3]
Blood lipidsCThe 2017 meta-analysis of 13 RCTs found no difference in total cholesterol, triglycerides, LDL or HDL cholesterol. [2]
Obese adults with borderline diabetesCIn a 12-week randomized study, leaf powder (12 mg DNJ three times daily) lowered fasting glucose by 3.86 mg/dL and HbA1c by 0.11% from baseline; glucose tolerance did not improve. [5]

Main constituents: 1-Deoxynojirimycin (DNJ), a potent alpha-glucosidase inhibitor; DNJ content of commercial mulberry products was as low as about 0.1% (100 mg/100 g of dry product) [4]; Phytochemicals mainly 1-deoxynojirimycin, flavonoids, phenolics and polysaccharides [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Mulberry leaf powder providing 12 mg DNJ three times daily for 12 weeks; 12 mg DNJ was the minimum effective dose for blunting the glucose rise after sucrose in the dose-finding phase. [5]
  • Single doses of 0.4, 0.8 and 1.2 g of DNJ-enriched leaf powder (6, 12 and 18 mg DNJ) with 50 g sucrose; 0.8 and 1.2 g suppressed the rise in blood glucose. [4]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    2 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • The most common adverse events in a 12-week trial were gastrointestinal: bloating, flatulence and loose stools. [5]
  • A meta-analysis of 13 RCTs reported no serious adverse effects in either the Morus alba or the control groups. [2]
Quality

Identity, quality and standardization

  • DNJ content varies with cultivar, harvest season and leaf position; in one study young leaves from the top of branches picked in summer had the most DNJ, measured by hydrophilic interaction chromatography with evaporative light scattering detection. [4]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • 1-Deoxynojirimycin (DNJ), described as a potent alpha-glucosidase inhibitor Polyhydroxylated piperidine (PubChem CID 29435: 2-(hydroxymethyl)piperidine-3,4,5-triol) [P1]
  • Flavonoids, phenolics and polysaccharides (named with DNJ as the main leaf phytochemicals) Flavonoids; phenolics; polysaccharides [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 2 entries naming mulberry (earliest NDI 275 submitted 2004-01-23; most recent NDI 630 submitted 2010-01-13, which names mulberry leaf powder derived from the leaf of Morus alba L.). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P5]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of white mulberry (Morus alba) or 1-deoxynojirimycin was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-29). [P6]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no study of mulberry, Morus or 1-deoxynojirimycin (checked 2026-10-29). [P7]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P8]
  • DNJ content assay (one published method: hydrophilic interaction chromatography with evaporative light scattering detection) — DNJ content of commercial mulberry products was as low as about 0.1% and varies with cultivar, harvest season and leaf position. [P1]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P9]

Absorption in people

  • Using a validated HILIC tandem mass spectrometry method in human plasma, orally administered mulberry DNJ was found to be absorbed into the blood and then excreted into the urine. [P4]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Kimura T, et al. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 2007;55(14):5869-5874 (PMID 17555327), 2007-07. pubmed.ncbi.nlm.nih.gov
  2. Cui W, et al. Effect of mulberry leaf or mulberry leaf extract on glycemic traits: a systematic review and meta-analysis. Food Funct 2023;14(3):1277-1289 (PMID 36644880), 2023-02. pubmed.ncbi.nlm.nih.gov
  3. PubChem. Duvoglustat (1-deoxynojirimycin), CID 29435: description (retrieved 2026-10-29), 2026-10-29. pubchem.ncbi.nlm.nih.gov
  4. Nakagawa K, et al. Validation of an ion trap tandem mass spectrometric analysis of mulberry 1-deoxynojirimycin in human plasma: application to pharmacokinetic studies. Biosci Biotechnol Biochem 2008;72(8):2210-2213 (PMID 18685194), 2008-08. pubmed.ncbi.nlm.nih.gov
  5. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  6. IARC Monographs. List of Classifications, Volumes 1–142 (retrieved 2026-10-29), 2026-10-29. monographs.iarc.who.int
  7. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; retrieved 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  8. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  9. GBIF species API: IUCN Red List category for Morus alba L., 2026-10-29. api.gbif.org
Sources

Sources

  1. Cui W, et al. Effect of mulberry leaf or mulberry leaf extract on glycemic traits: a systematic review and meta-analysis. Food Funct 2023;14(3):1277-1289 (PMID 36644880), 2023-02. pubmed.ncbi.nlm.nih.gov
  2. Phimarn W, et al. A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile. Eur J Nutr 2017;56(4):1509-1521 (PMID 26972284), 2017-06. pubmed.ncbi.nlm.nih.gov
  3. Jeong HI, Jang S, Kim KH. Morus alba L. for blood sugar management: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2022;2022:9282154 (PMID 35656460), 2022-05. pubmed.ncbi.nlm.nih.gov
  4. Kimura T, et al. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 2007;55(14):5869-5874 (PMID 17555327), 2007-07. pubmed.ncbi.nlm.nih.gov
  5. Thaipitakwong T, et al. A randomized controlled study of dose-finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes. Complement Ther Med 2020;49:102292 (PMID 32147046), 2020-03. pubmed.ncbi.nlm.nih.gov
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
  7. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Morus alba L. (accessed 2026-10-29; native range: "C. China"), 2026-10-29. powo.science.kew.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.